Artificial Urinary Sphincter Clinical Outcomes

CompletedOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions
Stress Urinary Incontinence
Interventions
DEVICE

AMS 800 Artificial Urinary Sphincter

The AMS 800 Artificial Urinary Sphincter (AUS) is an implantable, fluid filled, solid silicone elastomer device used to treat stress urinary incontinence due to reduced urethral/bladder outlet resistance (intrinsic sphincter deficiency). It is designed to restore the natural process of urinary control. The device simulates normal sphincter function by opening and closing the urethra under the control of the patient.

Trial Locations (18)

2139

Concord Repatriation General Hospital, Concord

3144

Australian Urology Associates, Melbourne

21287

Johns Hopkins Hospital, Baltimore

27103

Wake Forest University School of Medicine, Winston-Salem

27710

Duke University Medical Center, Durham

37232

Vanderbilt University Medical Center, Nashville

44195

Cleveland Clinic Foundation, Cleveland

52242

University of Iowa Hospitals and Clinics, Iowa City

55455

University of Minnesota Medical Center, Minneapolis

71111

Willis-Knighton Bossier Medical Center, Bossier City

77030

MD Anderson Cancer Center, Houston

The Methodist Hospital Research Institute, Houston

78229

Urology San Antonio Research, PA., San Antonio

80045

University of Colorado Hospital, Aurora

84132

University of Utah, Salt Lake City

94110

University of California, San Francisco, San Francisco

66160-7234

University of Kansas Hospital, Kansas City

01805

Lahey Clinic Hospital, Burlington

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY